Dow Down 0.56% Nasdaq Down 0.79%

More On TSPT

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(TSPT)

-NasdaqGS
0.00 0.00(0.00%) N/A
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.20
Beta:2.03
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.55 - 3.88
Volume:0
Avg Vol (3m):N/A
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for TSPT at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

As of October 30, 2014, Transcept Pharmaceuticals, Inc. was acquired by Paratek Pharmaceuticals, Inc., in a reverse merger transaction. Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commerciali... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback